211 At-Labeled Heterodimeric Peptide

N/A

Report date: 2025/11/27 17:57:19
NME

Base Information

Drug Name211 At-Labeled Heterodimeric Peptide
Drug Alias NameiRGD-C6-lys(211At-ATE)-C6-DA7R
ClassificationRadiation-emitting products > Nuclides > Astatine > 211AtSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Radiation-emitting products > Radioactive therapeutic agent +[4] 
Mechanisms of ActionRadionuclide imaging enhancersIntegrin bindersVascular endothelial growth factor receptor binders
TargetsIntegrinVascular endothelial growth factor receptor
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan UniversityChinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of SciencesSichuan University
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A